Stocktoria
Neumora Therapeutics, Inc. NMRA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-09-15
Neumora Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,603,394 | $45.3M | 2.64% |
| TWO SIGMA INVESTMENTS, LP | 2,244,829 | $3.8M | 1.29% |
| RENAISSANCE TECHNOLOGIES LLC | 1,262,304 | $2.1M | 0.72% |
| CITADEL ADVISORS LLC | 1,068,733 | $1.8M | 0.61% |
| MILLENNIUM MANAGEMENT LLC | 509,210 | $865,657 | 0.29% |
| AQR CAPITAL MANAGEMENT LLC | 13,613 | $23,143 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.